Fourth-Quarter and Full-Year 2019 Orphan and Rheumatology Segment Results slide image

Fourth-Quarter and Full-Year 2019 Orphan and Rheumatology Segment Results

TEPEZZA First and Only FDA-Approved Medicine for Patients with Thyroid Eye Disease HORIZON 13
View entire presentation